Literature DB >> 11181385

In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus.

M Boos1, S Mayer, A Fischer, K Köhrer, S Scheuring, P Heisig, J Verhoef, A C Fluit, F J Schmitz.   

Abstract

Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus isolates were exposed to subinhibitory MICs of ciprofloxacin, sparfloxacin, gatifloxacin, moxifloxacin, clinafloxacin, and gemifloxacin during a 10-day period. Subculturing led to resistance development, regardless of the initial potencies of the quinolones. None of the quinolones was associated with a significantly slower rate of resistance development.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11181385      PMCID： PMC90398          DOI： 10.1128/AAC.45.3.938-942.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  42 in total

1.  Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC.

Authors:  F J Schmitz; M E Jones; B Hofmann; B Hansen; S Scheuring; M Lückefahr; A Fluit; J Verhoef; U Hadding; H P Heinz; K Köhrer
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 2.  Natural functions of bacterial multidrug transporters.

Authors:  A A Neyfakh
Journal:  Trends Microbiol       Date:  1997-08       Impact factor: 17.079

Review 3.  DNA gyrase, topoisomerase IV, and the 4-quinolones.

Authors:  K Drlica; X Zhao
Journal:  Microbiol Mol Biol Rev       Date:  1997-09       Impact factor: 11.056

4.  Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae.

Authors:  V Zeller; C Janoir; M D Kitzis; L Gutmann; N J Moreau
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

5.  High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA.

Authors:  C Janoir; V Zeller; M D Kitzis; N J Moreau; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

6.  Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro.

Authors:  T D Gootz; R Zaniewski; S Haskell; B Schmieder; J Tankovic; D Girard; P Courvalin; R J Polzer
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

7.  Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis.

Authors:  E Kanematsu; T Deguchi; M Yasuda; T Kawamura; Y Nishino; Y Kawada
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

Review 8.  Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance.

Authors:  D C Hooper
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

9.  DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae.

Authors:  X S Pan; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

10.  Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  N P Brenwald; M J Gill; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191
View more
  9 in total

1.  Propensity of fluoroquinolones with different moieties at position 8 to cause resistance development in clinical isolates of Streptococcus pneumoniae.

Authors:  F J Schmitz; M Boos; S Mayer; D Hafner; H Jagusch; J Verhoef; A C Fluit
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

Review 2.  In vitro antibacterial activity and pharmacodynamics of new quinolones.

Authors:  A Dalhoff; F-J Schmitz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-04-01       Impact factor: 3.267

3.  Clonal spread of pediatric isolates of ciprofloxacin-resistant, emm type 6 Streptococcus pyogenes.

Authors:  Rodrigo Alonso; Estibaliz Mateo; Marc Galimand; Javier Garaizar; P Courvalin; Ramón Cisterna
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

4.  Activity of gemifloxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.

Authors:  E Azoulay-Dupuis; J P Bédos; J Mohler; P Moine; C Cherbuliez; G Peytavin; B Fantin; T Köhler
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

5.  In vitro activities of novel des-fluoro(6) quinolone BMS-284756 against mutants of Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus selected with different quinolones.

Authors:  Franz-Josef Schmitz; Mechthild Boos; Susanne Mayer; Karl Köhrer; Sibylle Scheuring; Ad C Fluit
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

6.  An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes.

Authors:  S Steve Yan; Paul C Schreckenberger; Xiaotian Zheng; Nancy A Nelson; Susan M Harrington; Joyce Tjhio; Daniel P Fedorko
Journal:  Diagn Microbiol Infect Dis       Date:  2008-06-12       Impact factor: 2.803

7.  Development and selection of low-level multi-drug resistance over an extended range of sub-inhibitory ciprofloxacin concentrations in Escherichia coli.

Authors:  Carly Ching; Muhammad H Zaman
Journal:  Sci Rep       Date:  2020-05-29       Impact factor: 4.379

8.  Mutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy.

Authors:  Delphine Croisier; Manuel Etienne; Emilie Bergoin; Pierre-Emmanuel Charles; Catherine Lequeu; Lionel Piroth; Henri Portier; Pascal Chavanet
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 9.  Bacterial antibiotic resistance development and mutagenesis following exposure to subinhibitory concentrations of fluoroquinolones in vitro: a systematic review of the literature.

Authors:  Carly Ching; Ebiowei S F Orubu; Indorica Sutradhar; Veronika J Wirtz; Helen W Boucher; Muhammad H Zaman
Journal:  JAC Antimicrob Resist       Date:  2020-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.